Literature DB >> 27469157

HIV-associated renal disease - an overview.

Nicola Wearne, Ikechi G Okpechi.   

Abstract

The cause of the human immunodeficiency virus (HIV) epidemic in South Africa (SA) was worsened by the denial by key political players that HIV causes acquired immunodeficiency syndrome (AIDS). South Africa continues to have the highest rate of HIV world-wide, which has had a huge impact on the development of both chronic kidney disease and acute kidney injury. Fortunately, there is now an effective antiretroviral therapy (ART) roll-out program. SA is also dealing with a collision of epidemics of HIV, tuberculosis, and non-communicable disease, particularly hypertension and diabetes. This has been evidenced by recent data seen in the reinstated SA renal registry. There is also an unacceptably high rate of tuberculosis in regions of SA, this has led to high rates of granulomatous interstitial nephritis (GIN) and case reports of TB-GIN immune reconstitution inflammatory syndrome (IRIS). HIV-associated nephropathy (HIVAN) remains common in SA and responds well to ART. The definitive diagnosis requires a renal biopsy, which is often not possible in many regions of sub-Saharan Africa. Unfortunately, there is still a high rate of HIVAN in SA due to late presentation and lack of effective screening for renal disease in HIV-positive patients. Transplantation for HIV-positive donors to positive recipients offers a unique and encouraging way forward for these patients.

Entities:  

Mesh:

Year:  2016        PMID: 27469157     DOI: 10.5414/CNP86S117

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  8 in total

Review 1.  Pharmacotherapy and treatment options for HIV-associated nephropathy.

Authors:  Steven Menez; Mohamad Hanouneh; Blaithin A McMahon; Derek M Fine; Mohamed G Atta
Journal:  Expert Opin Pharmacother       Date:  2017-12-26       Impact factor: 3.889

Review 2.  Kidney Transplantation in HIV-positive Patients: Current Practice and Management Strategies.

Authors:  Elmi Muller; Francois C J Botha; Zunaid A Barday; Kathryn Manning; Peter Chin-Hong; Peter Stock
Journal:  Transplantation       Date:  2021-07-01       Impact factor: 5.385

Review 3.  HIV-Associated Nephropathy in Africa: Pathology, Clinical Presentation and Strategy for Prevention.

Authors:  Nazik Elmalaika Husain; Mohamed H Ahmed; Ahmed O Almobarak; Sufian K Noor; Wadie M Elmadhoun; Heitham Awadalla; Clare L Woodward; Dushyant Mital
Journal:  J Clin Med Res       Date:  2017-12-01

Review 4.  Chronic kidney disease in low-income to middle-income countries: the case for increased screening.

Authors:  Cindy George; Amelie Mogueo; Ikechi Okpechi; Justin B Echouffo-Tcheugui; Andre Pascal Kengne
Journal:  BMJ Glob Health       Date:  2017-05-29

5.  Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa.

Authors:  P Bock; K Nel; G Fatti; R Sloot; N Ford; J Voget; C Gunst; N Grobbelaar; F Louis; S Floyd; R Hayes; H Ayles; N Beyers; S Fidler
Journal:  HIV Med       Date:  2019-04-08       Impact factor: 3.180

6.  Human resources for nephrology in South Africa: A mixed-methods study.

Authors:  Muhammed Hassen; Elize Archer; Adriano Pellizzon; Usuf M E Chikte; Mogamat Razeen Davids
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

7.  Pattern of renal amyloidosis in South Africa.

Authors:  Muhammed Hassen; William Bates; Mohammed Rafique Moosa
Journal:  BMC Nephrol       Date:  2019-11-09       Impact factor: 2.388

Review 8.  Establishing the presence or absence of chronic kidney disease: Uses and limitations of formulas estimating the glomerular filtration rate.

Authors:  Ahmed Alaini; Deepak Malhotra; Helbert Rondon-Berrios; Christos P Argyropoulos; Zeid J Khitan; Dominic S C Raj; Mark Rohrscheib; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  World J Methodol       Date:  2017-09-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.